Literature DB >> 8471403

A placebo controlled double-blind evaluation of the pharmacodynamics of fengabine vs amitriptyline following single and multiple doses in elderly volunteers.

D B Fairweather1, J S Kerr, S Hilton, I Hindmarch.   

Abstract

1. The effects of fengabine were compared with those of amitriptyline in healthy elderly volunteers. Doses were administered double-blind and assessments were made before and after ingestion. 2. Psychomotor performance and cognitive ability were measured using tests of choice reaction time, tracking, critical flicker fusion threshold, memory scanning and word recognition. Subjective feelings were assessed using the Leeds sleep evaluation questionnaire (LSEQ) and line analogue rating scales (LARS). 3. Pharmacokinetic data suggest that fengabine may induce its own metabolism following repeated dosing. 4. The findings of this study show that fengabine 200 mg and 400 mg does not produce any noticeable behavioural toxicity in elderly volunteers, in contrast to amitriptyline which had a disruptive effect throughout.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471403      PMCID: PMC1381575          DOI: 10.1111/j.1365-2125.1993.tb05695.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  The effects of alcohol and other drugs on psychomotor performance and cognitive function.

Authors:  I Hindmarch; J S Kerr; N Sherwood
Journal:  Alcohol Alcohol       Date:  1991       Impact factor: 2.826

2.  Factor analysis of a sleep evaluation questionnaire.

Authors:  A C Parrott; I Hindmarch
Journal:  Psychol Med       Date:  1978-05       Impact factor: 7.723

3.  Increased sensitivity to nitrazepam in old age.

Authors:  C M Castleden; C F George; D Marcer; C Hallett
Journal:  Br Med J       Date:  1977-01-01

4.  Memory-scanning: mental processes revealed by reaction-time experiments.

Authors:  S Sternberg
Journal:  Am Sci       Date:  1969       Impact factor: 0.548

5.  Benzodiazepines: clinical pharmacology and therapeutic use.

Authors:  C Bellantuono; V Reggi; G Tognoni; S Garattini
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

Review 6.  The gabaergic hypothesis of depression.

Authors:  K G Lloyd; B Zivkovic; B Scatton; P L Morselli; G Bartholini
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1989       Impact factor: 5.067

7.  Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double-blind study versus clomipramine.

Authors:  N P Nielsen; B Cesana; S Zizolfi; V Ascalone; P Priore; P L Morselli
Journal:  Acta Psychiatr Scand       Date:  1990-11       Impact factor: 6.392

8.  The effect of a sub-chronic administration of three dose levels of a 1,5-benzodiazepine derivative, clobazam, on subjective assessments of sleep and aspects of psychomotor performance the morning following night time medication.

Authors:  I Hindmarch; A C Parrott
Journal:  Arzneimittelforschung       Date:  1978

9.  The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability.

Authors:  I Hindmarch; A C Gudgeon
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

10.  An investigation of the effects of lofepramine, nomifensine, amitriptyline and placebo on aspects of memory and psychomotor performance related to car driving.

Authors:  I Hindmarch; C Harrison; C A Shillingford
Journal:  Int Clin Psychopharmacol       Date:  1988-04       Impact factor: 1.659

View more
  3 in total

1.  A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.

Authors:  Ian Hindmarch; Leanne Trick; Fran Ridout
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

Review 2.  A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs.

Authors:  Cara Tannenbaum; Amélie Paquette; Sarah Hilmer; Jayna Holroyd-Leduc; Ryan Carnahan
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

3.  Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.

Authors:  Julia Boyle; Malin E V Eriksson; Laura Gribble; Ravi Gouni; Sigurd Johnsen; David V Coppini; David Kerr
Journal:  Diabetes Care       Date:  2012-09-18       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.